Cantourage Group Past Earnings Performance

Past criteria checks 4/6

Cantourage Group has been growing earnings at an average annual rate of 402%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 63.1% per year. Cantourage Group's return on equity is 0.5%, and it has net margins of 11.3%.

Key information

402.0%

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate63.1%
Return on equity0.5%
Net Margin11.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Calculating The Intrinsic Value Of Cantourage Group SE (ETR:HIGH)

Jan 05
Calculating The Intrinsic Value Of Cantourage Group SE (ETR:HIGH)

Revenue & Expenses Breakdown

How Cantourage Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XTRA:HIGH Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242010
31 Mar 242010
31 Dec 232010
30 Sep 231010
30 Jun 231000
31 Dec 221000
31 Dec 215-110

Quality Earnings: HIGH has high quality earnings.

Growing Profit Margin: HIGH's current net profit margins (11.3%) are higher than last year (3.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: HIGH has become profitable over the past 5 years.

Accelerating Growth: Insufficient data to compare HIGH's past year earnings growth to its 5-year average.

Earnings vs Industry: HIGH earnings growth over the past year (402%) exceeded the Pharmaceuticals industry 25.4%.


Return on Equity

High ROE: HIGH's Return on Equity (0.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies